Article info
PDFTherapeutics
Randomised controlled trial
Tiotropium is superior to salmeterol in reducing frequency of exacerbations: but the effect of adding tiotropium to the combination of inhaled corticosteroid and long-acting β(2)-agonist remains unclear
- Correspondence to Rick Hodder
University of Ottawa, The Ottawa Hospital, 1053 Carling Ave, Ottawa, ON K1Y4E9, Canada; rhodder{at}toh.on.ca
Citation
Tiotropium is superior to salmeterol in reducing frequency of exacerbations: but the effect of adding tiotropium to the combination of inhaled corticosteroid and long-acting β(2)-agonist remains unclear
Publication history
- First published November 22, 2011.
Online issue publication
April 26, 2021
Article Versions
- Previous version (26 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions